Antibiotic-Resistant Infections
A growing number of disease-causing bacteria, or pathogens, are resistant to one or more antibiotic medications. NYU Langone doctors are experts at identifying antibiotic-resistant infections.
Antibiotics have been used for decades to treat people with infections caused by a variety of bacteria. These medications have dramatically reduced the rates of illness and death from conditions such as tuberculosis and pneumonia. However, certain antibiotics have been used so widely and for so long that some bacteria have become resistant to them, rendering treatment less effective.
Common types of resistant pathogens include methicillin-resistant Staphylococcus aureus, known as MRSA, and carbapenem-resistant Enterobacteriaceae.
Treatment for Antibiotic-Resistant Infections
NYU Langone experts treat antibiotic-resistant infections with medications that target the bacteria causing the infection. Sometimes they prescribe a combination of medications.
Our Research and Education in Antibiotic-Resistant Infections
Learn more about our research and professional education opportunities.
Related News
-
COVID-19 Infection Can Disrupt Gut Bacteria Diversity
-
Making Bacteria More Vulnerable to Common Antibiotics
-
Hydrogen Sulfide Plays a Key Role in Antibiotic Tolerance
-
New Vaccine Strategy Emerges Against MRSA
-
New Model for Community-Based Infection Surveillance
-
Bacteria Fight for Territory like Wasps
-
DNA Sequencing Technique Helps Spot Cancer Mutations Earlier
-
Early Antibiotic Overexposure Linked to Metabolic Disorders
-
Study IDs Difficult Path for MRSA Vaccine
-
NYU Langone Leads MRSA Study